Charles Schwab’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.43M | Buy |
|
|||||
|
2025
Q2 | $6.13M | Buy |
|
|||||
|
2025
Q1 | $5.11M | Sell |
|
|||||
|
2024
Q4 | $5.89M | Buy |
|
|||||
|
2024
Q3 | $6.52M | Buy |
|
|||||
|
2024
Q2 | $5.4M | Buy |
|
|||||
|
2024
Q1 | $2.8M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Buy |
|
|||||
|
2023
Q3 | $2.14M | Buy |
|
|||||
|
2023
Q2 | $1.27M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $47.1K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $145K | Sell |
|
|||||
|
2021
Q1 | $285K | Sell |
|
|||||
|
2020
Q4 | $775K | Buy |
|
|||||
|
2020
Q3 | $650K | Sell |
|
|||||
|
2020
Q2 | $904K | Buy |
|